A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.

医学 内科学 B组 前瞻性队列研究 酊剂(纹章学) 胃肠病学 外科 传统医学
作者
Chen Lm,Cong Qi,Deqing Wu,Pei‐Jer Chen,Lugui Qiu,Zhi-Jie Hong,Ying Yang,Xu Liu,Wang Lf,Li Huang,W-R Li,Jiyu Tang,Yongli Cao,Lu-Lu Sui
出处
期刊:PubMed [National Institutes of Health]
卷期号:27 (19): 8985-8992
标识
DOI:10.26355/eurrev_202310_33922
摘要

The aim of the study was to investigate the safety and antiviral efficacy of a Chinese multiherb extract-based tincture (GWK) on a population of patients with high-risk human papilloma (hrHPV) infections and hrHPV-caused cervical low-grade squamous intraepithelial lesions (LSILs).Patients with persistent hrHPV infection were enrolled in Group A, including A1 subjects, who received the intervention, and A2 subjects, who received the control. Patients with hrHPV infection causing cervical LSIL were enrolled in Group B, which included B1 subjects, who received the intervention, and B2 subjects, who served as the control. For Groups A1 and B1, hrHPV was tested at 3 months (M3) and 6 months (M6) after the intervention. The side effects were also analyzed.At baseline (D0), a total of 99 patients were enrolled in Group A, with 50 subjects in Group A1 and 49 subjects in Group A2. A total of 91 patients were enrolled in Group B, with 45 subjects in Group B1 and 46 subjects in Group B2. There was no significant difference in the characteristics, including average age, age stratification, and HPV genotype. At M6, both Group A1 and Group B1 had a higher hrHPV clearance rate than the control group (A1/A2: 80.0% vs. 20.4%; B1/B2: 64.4% vs. 15.2%, p<0.001). At M6, the effective rates of Group A1 and Group B1 were 84% (42/50) and 68.9% (31/45), respectively. The side effect rates of Groups A1 and B1 were 11.5% (6/52) and 11.1% (5/45), respectively. Most adverse reactions involved local discomfort, including vulvar erythema, vulvar itch, increased vaginal discharge, cervical bleeding, and mild pain in the lower abdomen. Univariate logistic regression analysis showed that the intervention had an OR of 12 (95% CI 4.431-32.50) for clearing persistent HPV infection (p<0.001). For cervical LSIL, the intervention had an OR of 10.1 for clearing persistent HPV infection (95% CI 3.68-27.7) (p<0.001).The results of this study suggest that the Chinese multiherb extract-based tincture GWK is safe and well tolerated. Furthermore, this preliminary study showed that this Chinese multiherb extract-based tincture is helpful for promoting HPV clearance in cases of persistent HPV and HPV-induced LSIL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
细腻傲柔发布了新的文献求助10
1秒前
Parrot_PAI发布了新的文献求助10
2秒前
3秒前
4秒前
4秒前
lll的应助被爱听歌的怀柔采纳,获得10
4秒前
echo发布了新的文献求助10
5秒前
lei完成签到,获得积分10
5秒前
5秒前
蔺文博完成签到,获得积分10
5秒前
5秒前
虚心沂发布了新的文献求助10
6秒前
ttt发布了新的文献求助10
7秒前
7秒前
7秒前
8秒前
ZDSHI发布了新的文献求助30
8秒前
8秒前
8秒前
Search瞬间发布了新的文献求助10
8秒前
liang完成签到,获得积分10
9秒前
9秒前
Konstanzejin发布了新的文献求助10
10秒前
于国蕊完成签到 ,获得积分10
10秒前
11秒前
罗健的偶像的应助被跑跑采纳,获得10
11秒前
矮小的战斗机完成签到,获得积分20
11秒前
悦耳的映寒完成签到,获得积分10
12秒前
gaodeng发布了新的文献求助10
12秒前
12秒前
中国大陆发布了新的文献求助10
12秒前
彳亍完成签到,获得积分10
12秒前
可爱的函函的应助被刘金磊采纳,获得10
13秒前
13秒前
沈xxx发布了新的文献求助10
13秒前
852的应助被zzz采纳,获得10
13秒前
13秒前
吕布发布了新的文献求助10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 530
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7869321
求助须知:如何正确求助?哪些是违规求助? 9386343
关于积分的说明 20758712
捐赠科研通 7470470
什么是DOI,文献DOI怎么找? 3350226
关于科研通互助平台的介绍 2491268
邀请新用户注册赠送积分活动 2376596